BR
Bruehlman Ronald E
Autre
OtherM
内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Bruehlman Ronald E, Autre. Insider active across 2 companies, notably Iqvia Holdings INC.. Cumulatively, 19 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €4k. Activity tracked since 3 August 2021. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bruehlman Ronald E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
73,434 股Class A Common StockSEC:0001809519-26-000125:0
4,642 股0Class A Common StockSEC:0001809519-26-000117:0
16,335 股0Common StockSEC:0001628280-26-006952:0
18,251 股0Class A Common StockSEC:0001809519-26-000003:0
21,691 股Class A Common StockSEC:0001809519-25-000145:0
57,050 股0Class A Common StockSEC:0001809519-25-000090:0
907 股@ US$206.979.2% 占其流量Common StockSEC:0001478242-25-000037:0
6,286 股0Common StockSEC:0001478242-25-000008:0
10,653 股0Class A Common StockSEC:0001809519-25-000002:0
1,128 股0Class A Common StockSEC:0001809519-24-000202:0
1,033 股@ US$218.2010.6% 占其流量Common StockSEC:0001478242-24-000027:0
24,141 股0Common StockSEC:0001478242-24-000016:0
2,588 股@ US$216.2925.9% 占其流量Common StockSEC:0001478242-23-000089:0
717 股@ US$230.317.8% 占其流量Common StockSEC:0001478242-23-000028:0
2,588 股@ US$233.2130.2% 占其流量Common StockSEC:0001478242-22-000090:0
4 股@ US$262.820.0% 占其流量Common StockSEC:0001478242-22-000043:0
13 股@ US$245.320.1% 占其流量Common StockSEC:0001478242-22-000022:0
705 股@ US$255.578.7% 占其流量Common StockSEC:0001478242-22-000020:0
2,391 股0Common StockSEC:0001478242-21-000052:0
About Bruehlman Ronald E
Bruehlman Ronald E is Autre and appears in 19 filings in total. In the recent filings tracked, the reported buy amount is EUR 3602, the reported sell amount is EUR 0, and the period runs from 2021-08-05 to 2026-06-17. The listed companies are Iqvia Holdings INC., where the stated role is See Remarks, and GoodRx Holdings, Inc., where he is Director. The modal transaction nature is Attribution.